4 Publications
2020
Enhancing anticancer activity of checkpoint immunotherapy by targeting RAS
Ward, AB⋅Ward, Antonio B⋅Ward, Antonio B⋅Keeton, Ab⋅Keeton, Adam B⋅Keeton, Adam B⋅Chen, X⋅Chen, Xi⋅Chen, Xi⋅Mattox, TE⋅Mattox, Tyler E⋅Mattox, Tyler E⋅Coley, AB⋅Coley, Alex B⋅Coley, Alex B⋅Maxuitenko, Yulia Y⋅Maxuitenko, Yulia Y⋅Maxuitenko, YY⋅Buchsbaum, Donald J⋅Buchsbaum, Donald J⋅Buchsbaum, Dj⋅Randall, Troy D⋅Randall, Troy D⋅Randall, TD⋅Zhou, Gang⋅Zhou, Gang⋅Zhou, G⋅Piazza, Gary A⋅Piazza, GA and Piazza, Gary A
Medcomm, vol. 1, (no. 2), pp. 121-128, Sep 2020. | Journal Article
2014
Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4'-thio-2'-deoxycytidine and 5-aza-4'-thio-2'-deoxycytidine
Thottassery, Jaideep V⋅Sambandam, Vijaya⋅Allan, Paula W⋅Maddry, Joseph A⋅Maxuitenko, Yulia Y⋅Tiwari, Kamal⋅Hollingshead, Melinda and Parker, William B
Cancer Chemotherapy and Pharmacology, vol. 74, (no. 2), pp. 291-302, Aug 2014. | Journal Article
2007
Sorafenib is efficacious and tolerated in combination with cytotoxic or cytostatic agents in preclinical models of human non-small cell lung carcinoma
Carter, Christopher A⋅Chen, Charles⋅Brink, Cheryl⋅Vincent, Patrick⋅Maxuitenko, Yulia Y⋅Gilbert, Karen S⋅Waud, William R and Zhang, Xiaomei
Cancer Chemotherapy and Pharmacology, vol. 59, (no. 2), pp. 183-95, Feb 2007. | Journal Article
2003
A novel polyamine analog (SL-11093) inhibits growth of human prostate tumor xenografts in nude mice
Frydman, Benjamin⋅Frydman, Benjamin⋅Porter, Carl W⋅Porter, Carl W⋅Maxuitenko, Yulia⋅Maxuitenko, Yulia⋅Sarkar, Aparajita⋅Sarkar, Aparajita⋅Bhattacharya, Subhra⋅Bhattacharya, Subhra⋅Valasinas, Aldonia⋅Valasinas, Aldonia⋅Reddy, Venodhar K⋅Reddy, Venodhar K⋅Kisiel, Nick⋅Kisiel, Nick⋅Marton, Laurence J⋅Marton, Laurence J⋅Basu, Hirak S and Basu, Hirak S
Cancer Chemotherapy and Pharmacology, vol. 51, (no. 6), pp. 488-92, Jun 2003. | Journal Article